Corvex, Inc. has announced a major development in its business strategy with the signing of a definitive three-year, $103 million take-or-pay agreement to provide NVIDIA Blackwell computing capacity for a scaled AI inference platform. This agreement is a significant milestone for the company, reflecting its commitment to expanding its capabilities in the rapidly growing AI sector.
The agreement, disclosed in a recent SEC filing, outlines that Corvex will deliver over 1,000 NVIDIA HGX B200 GPUs connected with NVIDIA Quantum-2 InfiniBand networking. The deployment is set to begin in the first quarter of 2027, positioning Corvex to capitalize on the increasing demand for AI computing resources.
Background
Corvex, Inc., incorporated in Delaware, operates within the computer processing and data preparation industry, classified under SIC 7374. The company trades on the Nasdaq under the ticker symbol MOVE. Recent filings indicate a proactive approach to securing financing and expanding its operational capabilities, including a recent 10-Q filing on November 12, 2026.
What the Filing Says
According to the filing dated November 16, 2026, Corvex stated, "On November 16, 2026, Corvex, Inc. ... announced that it has signed a definitive three-year, $103 million take-or-pay agreement to provide NVIDIA Blackwell computing capacity to a scaled AI inference platform." The filing further details that the deployment will involve significant investment in GPU servers, storage, and networking.
Impact
This agreement is expected to have a substantial impact on Corvex's operations and financial performance. The company anticipates that the $103 million deal will enhance its revenue stream, as it is committed under take-or-pay terms, ensuring payments regardless of utilization. The deal also includes a $26 million customer prepayment and $38 million in anticipated debt financing through USD.AI, which is crucial for covering the deployment costs.
What's Next
Corvex is set to proceed with the deployment of the NVIDIA computing capacity, with the expectation of beginning deliveries in early 2027. The filing does not specify additional upcoming events or filings related to this agreement.
Source: SEC Filing Accession Number 0001213900-26-120168
Read Next
Alpha Tau Medical Reports Positive Interim Results from REGAIN Trial
TOYO Co., Ltd Reports Q3 2026 Results in Latest Filing
NN Inc. to Present at Craig-Hallum Alpha Select Conference
Fresco Gutierrez Diego sells shares of StoneCo Ltd.
Ciena Corp appoints new Chief Product Officer amid changes
Shell plc's Dick Boer Nominated for Philips Supervisory Board









